Micro-RNA Expression and Function in Lymphomas

The recent discovery of microRNAs (miRNAs) has introduced a new layer of complexity to the process of gene regulation. MiRNAs are essential for cellular function, and their dysregulation often results in disease. Study of miRNA expression and function in animal models and human lymphomas has improved our knowledge of the pathogenesis of this heterogeneous disease. In this paper, we attempt to describe the expression of miRNAs and their function in lymphomas and discuss potential miRNA-based therapies in the diagnosis and treatment of lymphomas.

[1]  Dereje D. Jima,et al.  Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. , 2010, Blood.

[2]  E. Furth,et al.  The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. , 2010, Cancer research.

[3]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[4]  L. Leoncini,et al.  Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma , 2010, PloS one.

[5]  J. Chi,et al.  MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. , 2010, Blood.

[6]  Francesco Bertoni,et al.  Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B‐cell lymphomas , 2009, Hematological oncology.

[7]  J. Cigudosa,et al.  Mantle cell lymphoma: transcriptional regulation by microRNAs , 2010, Leukemia.

[8]  A. Carbone,et al.  B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. , 2010, Human pathology.

[9]  Tint Lwin,et al.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. , 2010, Blood.

[10]  K. Kok,et al.  MiRNA profiling in B non‐Hodgkin lymphoma: a MYC‐related miRNA profile characterizes Burkitt lymphoma , 2010, British journal of haematology.

[11]  Doron Betel,et al.  Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.

[12]  S. Lowe,et al.  miR-19 is a key oncogenic component of mir-17-92. , 2009, Genes & development.

[13]  F. Slack,et al.  Regression of murine lung tumors by the let-7 microRNA , 2009, Oncogene.

[14]  F. Speleman,et al.  Comparison of miRNA profiles of microdissected Hodgkin/Reed‐Sternberg cells and Hodgkin cell lines versus CD77+ B‐cells reveals a distinct subset of differentially expressed miRNAs , 2009, British journal of haematology.

[15]  L. Leoncini,et al.  Role of EBV in microRNA dysregulation in Burkitt lymphoma. , 2009, Seminars in cancer biology.

[16]  Keara M. Lane,et al.  Dicer1 functions as a haploinsufficient tumor suppressor. , 2009, Genes & development.

[17]  Ricardo C T Aguiar,et al.  Targeting of SMAD5 Links MicroRNA-155 to the TGFβ Pathway and Lymphomagenesis. , 2009 .

[18]  L. Fayad,et al.  Beyond R-CHOP and the IPI in large-cell lymphoma: Molecular markers as an opportunity for stratification , 2009, Current hematologic malignancy reports.

[19]  C. Sotiriou,et al.  Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. , 2009, Blood.

[20]  C. Croce,et al.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. , 2009, Blood.

[21]  R. Aguiar,et al.  Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. , 2009, Blood.

[22]  J. Lu,et al.  Controlled delivery of antisense oligonucleotides: a brief review of current strategies , 2009, Expert opinion on drug delivery.

[23]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[24]  Dereje D. Jima,et al.  Patterns of microRNA expression characterize stages of human B-cell differentiation. , 2009, Blood.

[25]  Ryan M. O’Connell,et al.  Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.

[26]  Peter Möller,et al.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. , 2009, Neoplasia.

[27]  J. Chi,et al.  Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma , 2008, Journal of cellular and molecular medicine.

[28]  Robert Tibshirani,et al.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. , 2008, Blood.

[29]  A. Rosenwald,et al.  Molecular pathogenesis of follicular lymphoma , 2008, Haematologica.

[30]  N. Harris,et al.  Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. , 2008, Blood.

[31]  Mauro Biffoni,et al.  The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.

[32]  Xiaowei Wang,et al.  A Functional MicroRNA-155 Ortholog Encoded by the Oncogenic Marek's Disease Virus , 2008, Journal of Virology.

[33]  A. Rossi,et al.  Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway , 2008, Nucleic acids research.

[34]  M. Ziepert,et al.  MicroRNA signatures characterize diffuse large B‐cell lymphomas and follicular lymphomas , 2008, British journal of haematology.

[35]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[36]  T. Tuschl,et al.  Tumorigenesis and Neoplastic Progression MicroRNA-Mediated Down-Regulation of PRDM 1 / Blimp-1 in Hodgkin / Reed-Sternberg Cells : A Potential Pathogenetic Lesion in Hodgkin Lymphomas , 2010 .

[37]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[38]  Guido Marcucci,et al.  Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. , 2008, Cancer research.

[39]  S. Kauppinen,et al.  LNA-mediated microRNA silencing in non-human primates , 2008, Nature.

[40]  Jing Wang,et al.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes , 2008, Nature Immunology.

[41]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[42]  A. López-Guillermo,et al.  MicroRNA expression profiling in classic Hodgkin lymphoma. , 2008, Blood.

[43]  R. Aguiar,et al.  Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. , 2008, Cancer genetics and cytogenetics.

[44]  Erik Flemington,et al.  B-cell Receptor Activation Induces BIC/miR-155 Expression through a Conserved AP-1 Element* , 2008, Journal of Biological Chemistry.

[45]  L. Lim,et al.  MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression , 2008, Molecular and Cellular Biology.

[46]  N. Caplen,et al.  Pvt1-encoded microRNAs in oncogenesis , 2008, Retrovirology.

[47]  Bryan R. Cullen,et al.  A viral microRNA functions as an orthologue of cellular miR-155 , 2007, Nature.

[48]  Yukio Kitade,et al.  Downregulation of microRNAs‐143 and ‐145 in B‐cell malignancies , 2007, Cancer science.

[49]  Muller Fabbri,et al.  Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.

[50]  S. Hammond.  Soaking up small RNAs , 2007, Nature Methods.

[51]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[52]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[53]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[54]  C. Croce,et al.  MicroRNA genes are frequently located near mouse cancer susceptibility loci , 2007, Proceedings of the National Academy of Sciences.

[55]  N. Rajewsky,et al.  Regulation of the Germinal Center Response by MicroRNA-155 , 2007, Science.

[56]  Anton J. Enright,et al.  Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.

[57]  Shuomin Zhu,et al.  miR-21-mediated tumor growth , 2007, Oncogene.

[58]  I. Zuhorn,et al.  Gene delivery by cationic lipid vectors: overcoming cellular barriers , 2007, European Biophysics Journal.

[59]  J. Rossi,et al.  RNAi therapeutics: principles, prospects and challenges. , 2007, Advanced drug delivery reviews.

[60]  M. Fraga,et al.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. , 2007, Cancer research.

[61]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[62]  B. Jungnickel,et al.  Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. , 2005, Blood.

[63]  R. Shiekhattar,et al.  Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing , 2005, Cell.

[64]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[65]  A. van den Berg,et al.  BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.

[66]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[67]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[68]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[69]  Wayne Tam,et al.  Accumulation of miR-155 and BIC RNA in human B cell lymphomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Wengel,et al.  LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. , 2004, Biochemistry.

[71]  A. Bradley,et al.  Identification of mammalian microRNA host genes and transcription units. , 2004, Genome research.

[72]  Hiroyuki Tagawa,et al.  Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.

[73]  John G Doench,et al.  Specificity of microRNA target selection in translational repression. , 2004, Genes & development.

[74]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[75]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[76]  V. Kim,et al.  MicroRNA maturation: stepwise processing and subcellular localization , 2002, The EMBO journal.

[77]  Meland,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[78]  I. Constable,et al.  The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides , 2001, Biomaterials.

[79]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[80]  W. S. Hayward,et al.  bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA , 1997, Molecular and cellular biology.

[81]  L. Staudt,et al.  Mechanisms of Disease , 2010 .

[82]  E. Jaffe,et al.  The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. , 2009, Hematology. American Society of Hematology. Education Program.

[83]  M. Trepel,et al.  Adeno-associated viral vectors and their redirection to cell-type specific receptors. , 2009, Advances in genetics.

[84]  R. Küppers.  Molecular biology of Hodgkin lymphoma. , 2009, Hematology. American Society of Hematology. Education Program.

[85]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Y. Pekarsky,et al.  Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.

[87]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[88]  The Myc – miR-17 ∼ 92 Axis Blunts TGF β Signaling and Production of Multiple TGF β -Dependent Antiangiogenic Factors , 2022 .